Leonid Bajenov, MD, DSc, Professor, Republican Specialised Centre of Surgery, Tashkent, Republic of Uzbekistan. Dr. Bajenov published more than 300 scientific works. He is currently conducting clinical trials of Coley Fluid.

Zuhal Butuner, OD, MSc, MBA is a clinical development advisor and has experience in both the pharmaceutical and medical device sectors.   Her tenure has included senior management and consultancy roles at Biogen, Controlled Delivery Systems, Bausch & Lomb Pharma and QLT Inc. and has been involved in the submission and approval of numerous INDs, 510Ks and one NDA.  Dr. Butuner has been involved in clinical development plans globally and has directed clinical trials in both North America and Europe.

Peter Coy, M.D., is a retired radiation oncologist, formerly director of the Victoria Cancer Centre and clinical assistant professor at the University of British Columbia. As chair of the lung cancer sub-committee of the National Cancer Institute of Canada Clinical Trials Committee, Dr. Coy was involved in the completion of five multi institutional clinical trials in lung cancer using combinations of surgery, radiation, chemotherapy and immunotherapy.

Hal Gunn, M.D., is a co-founder and chief executive officer of InspireHealth, Vancouver, BC, a non-profit integrative cancer care centre funded by the Medical Services Plan of BC, Foundations and individuals interested in supporting integrative care.  Dr. Gunn and other physicians at InspireHealth have used bacterial vaccines in the treatment of cancer, and has a clinical appointment with the University of British Columbia School of Medicine.

Kenneth Wilson, M.D., is a medical oncologist at the Vancouver Island Cancer Centre and a clinical Professor of Medicine at the University of British Columbia. Dr. Wilson has published more than 150 papers and communications, and is a member of the American Society of Clinical Oncology and the Canadian Association of Medical Oncologists.